BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10710827)

  • 21. [Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].
    Fiasse R; Denis MA; Dewit O
    J Pharm Belg; 2010 Mar; (1):1-9. PubMed ID: 20432590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifaximin for the treatment of irritable bowel syndrome.
    Cremonini F; Lembo A
    Expert Opin Pharmacother; 2012 Feb; 13(3):433-40. PubMed ID: 22251066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis.
    Brigidi P; Swennen E; Rizzello F; Bozzolasco M; Matteuzzi D
    J Chemother; 2002 Jun; 14(3):290-5. PubMed ID: 12120885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use and safety of rifaximin in children with inflammatory bowel disease.
    Muniyappa P; Gulati R; Mohr F; Hupertz V
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):400-4. PubMed ID: 19668011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing therapy for inflammatory bowel disease.
    Robinson M
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammatory bowel disease: an overview].
    Herrlinger K
    Med Monatsschr Pharm; 2013 Nov; 36(11):402-8; quiz 409. PubMed ID: 24640117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction: understanding mechanisms of the actions of rifaximin in selected gastrointestinal diseases.
    DuPont HL
    Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():1-2. PubMed ID: 26618920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders.
    Adachi JA; DuPont HL
    Clin Infect Dis; 2006 Feb; 42(4):541-7. PubMed ID: 16421799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics for inflammatory bowel disease: a critical appraisal.
    Sans M
    Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of anti(myco)bacterial interventions in the management of IBD: is there evidence at all?
    Pineton de Chambrun GP; Torres J; Darfeuille-Michaud A; Colombel JF
    Dig Dis; 2012; 30(4):358-67. PubMed ID: 22796797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
    Ohkusa T; Sato N
    J Gastroenterol Hepatol; 2005 Mar; 20(3):340-51. PubMed ID: 15740475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifaximin for active ulcerative colitis.
    Guslandi M; Petrone MC; Testoni PA
    Inflamm Bowel Dis; 2006 Apr; 12(4):335. PubMed ID: 16633057
    [No Abstract]   [Full Text] [Related]  

  • 36. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.
    Gionchetti P; Rizzello F; Ferrieri A; Venturi A; Brignola C; Ferretti M; Peruzzo S; Miglioli M; Campieri M
    Dig Dis Sci; 1999 Jun; 44(6):1220-1. PubMed ID: 10389700
    [No Abstract]   [Full Text] [Related]  

  • 37. Inflammatory bowel disease: short- and long-term treatments.
    Bickston SJ; Cominelli F
    Adv Intern Med; 1998; 43():143-74. PubMed ID: 9506181
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    Marteau P; Sokol H; Dray X; Seksik P
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S228-34. PubMed ID: 20117346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of antibiotics in the treatment of inflammatory bowel disease.
    Perencevich M; Burakoff R
    Inflamm Bowel Dis; 2006 Jul; 12(7):651-64. PubMed ID: 16804403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of inflammatory bowel disease with antibiotics.
    Isaacs KL; Sartor RB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):335-45, x. PubMed ID: 15177542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.